10:36 AM EDT, 03/21/2024 (MT Newswires) -- Mineralys Therapeutics ( MLYS ) on Thursday filed a registration statement with the US Securities and Exchange Commission to sell up to $500 million of its securities from time to time.

The securities may include common shares, preferred shares, debt securities, warrants, and units, the company added.

Mineralys said that stockholders may also sell up to about 8.9 million of the company's common shares.

Shares of the company were down more than 2% in recent trading.

Price: 13.02, Change: -0.37, Percent Change: -2.76